CBIZ REPORTS THIRD-QUARTER AND NINE-MONTH 2022 RESULTS AND INCREASES FULL-YEAR 2022 GUIDANCE
THIRD-QUARTER HIGHLIGHTS:
- TOTAL REVENUE UP 28.5%; SAME-UNIT REVENUE UP 12.3%
- GAAP EPS UP 29.3%; ADJUSTED EPS UP 24.4%
- INCOME FROM CONTINUING OPERATIONS UP 26.6%; ADJUSTED EBITDA UP 23.1%
NINE-MONTH HIGHLIGHTS:
- TOTAL REVENUE UP 29.6%; SAME-UNIT REVENUE UP 11.1%
- GAAP EPS UP 48.0%; ADJUSTED EPS UP 25.5%
- INCOME FROM CONTINUING OPERATIONS UP 45.1%; ADJUSTED EBITDA UP 26.7%
2022 OUTLOOK:
- TOTAL REVENUE GROWTH INCREASED TO 26% - 28%
- GAAP EPS INCREASED TO 48% - 51%
- ADJUSTED EPS INCREASED TO 26% - 28%
For the 2022 third quarter, CBIZ recorded revenue of
Adjusted income from continuing operations was
For the nine months ended
Adjusted income from continuing operations was
As previously announced in the second quarter of 2021, the Company recorded a nonrecurring settlement charge of
During the nine months ended
2022 Outlook
- The Company increased its revenue growth expectations to within a range of 26% to 28% over the prior year, up from previous guidance of 23% to 25% in revenue growth.
- On a GAAP basis, the Company expects full-year fully diluted earnings per share from continuing operations to grow within a range of 48% to 51% per share over the
$1.32 per share reported in 2021, up from previous guidance of 45% to 48% growth per share. - The Company expects Adjusted fully diluted earnings per share from continuing operations to grow within a range of 26% to 28% over the Adjusted
$1.66 reported for 2021, up from previous guidance of a 25% to 27% increase per share. A schedule reconciling GAAP Diluted EPS to Non-GAAP Adjusted Diluted EPS is attached. - Although multiple factors may impact the tax rate, the Company expects an effective tax rate of approximately 25%.
- The Company expects a weighted average fully diluted share count of 52.5 million to 53.0 million shares.
Conference Call
CBIZ will host a conference call at
About CBIZ
CBIZ is a leading provider of financial, insurance and advisory services to businesses throughout
Forward-Looking Statements
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the impact of COVID-19 on the Company's business and operations and those of our clients; the Company's ability to adequately manage and sustain its growth; the Company's dependence on the current trend of outsourcing business services; the Company's dependence on the services of its CEO and other key employees; competitive pricing pressures; general business and economic conditions; and changes in governmental regulation and tax laws affecting the Company's insurance business or its business services operations. A more detailed description of such risks and uncertainties may be found in the Company's filings with the
|
|
||||||||
|
FINANCIAL HIGHLIGHTS (UNAUDITED) |
||||||||
|
THREE MONTHS ENDED |
||||||||
|
(In thousands, except percentages and per share data) |
||||||||
|
Three Months Ended |
||||||||
|
2022 |
% |
2021 |
% |
|||||
|
Revenue |
|
100.0 % |
|
100.0 % |
||||
|
Operating expenses (1) |
306,017 |
84.2 |
238,328 |
84.3 |
||||
|
Gross margin |
57,245 |
15.8 |
44,391 |
15.7 |
||||
|
Corporate general and administrative expenses (1) |
15,893 |
4.4 |
13,035 |
4.6 |
||||
|
Operating income |
41,352 |
11.4 |
31,356 |
11.1 |
||||
|
Other (expense) income: |
||||||||
|
Interest expense |
(2,305) |
(0.6) |
(1,016) |
(0.4) |
||||
|
Gain on sale of operations, net |
176 |
— |
— |
— |
||||
|
Other expense, net (1) (2) |
(2,618) |
(0.7) |
(1,133) |
(0.4) |
||||
|
Total other expense, net |
(4,747) |
(1.3) |
(2,149) |
(0.8) |
||||
|
Income from continuing operations before income tax expense |
36,605 |
10.1 |
29,207 |
10.3 |
||||
|
Income tax expense |
9,131 |
7,512 |
||||||
|
Income from continuing operations |
27,474 |
7.6 |
21,695 |
7.7 |
||||
|
Loss from operations of discontinued businesses, net of tax |
(4) |
(4) |
||||||
|
Net Income |
$ 27,470 |
7.6 % |
$ 21,691 |
7.7 % |
||||
|
Diluted income per share: |
||||||||
|
Continuing operations |
$ 0.53 |
$ 0.41 |
||||||
|
Discontinued operations |
— |
— |
||||||
|
Net income |
$ 0.53 |
$ 0.41 |
||||||
|
Diluted weighted average common shares outstanding |
52,238 |
53,226 |
||||||
|
Other data from continuing operations: |
||||||||
|
Adjusted EBITDA (3) |
$ 45,865 |
$ 37,268 |
||||||
|
Adjusted EPS (3) |
$ 0.51 |
$ 0.41 |
||||||
|
(1) |
CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other expense, net." The deferred compensation plan has no impact on "Income from continuing operations before income tax expense." |
|
Income and expenses related to the deferred compensation plan for the three months ended |
|
Three Months Ended |
||||||||
|
2022 |
% of Revenue |
2021 |
% of Revenue |
|||||
|
Operating income |
$ (3,995) |
(1.1) % |
$ (212) |
(0.1) % |
||||
|
Corporate general and administrative income |
(697) |
(0.2) % |
(86) |
— % |
||||
|
Other expense, net |
(4,692) |
(1.3) % |
(298) |
(0.1) % |
||||
|
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the three months ended |
|
Three Months Ended |
|||||||||||||||
|
2022 |
2021 |
||||||||||||||
|
As |
Deferred |
Adjusted |
% of |
As |
Deferred |
Adjusted |
% of |
||||||||
|
Gross margin |
$ 57,245 |
$ (3,995) |
$ 53,250 |
14.7 % |
$ 44,391 |
$ (212) |
$ 44,179 |
15.6 % |
|||||||
|
Operating income |
41,352 |
(4,692) |
36,660 |
10.1 % |
31,356 |
(298) |
31,058 |
11.0 % |
|||||||
|
Other (expense) income, net |
(2,618) |
4,692 |
2,074 |
0.6 % |
(1,133) |
298 |
(835) |
(0.3) % |
|||||||
|
Income from continuing operations |
36,605 |
— |
36,605 |
10.1 % |
29,207 |
— |
29,207 |
10.3 % |
|||||||
|
(2) |
Included in "Other expense, net" for the three months ended |
|
(3) |
Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors. |
|
|
||||||||
|
FINANCIAL HIGHLIGHTS (UNAUDITED) |
||||||||
|
NINE MONTHS ENDED |
||||||||
|
(In thousands, except percentages and per share data) |
||||||||
|
Nine Months Ended |
||||||||
|
2022 |
% |
2021 |
% |
|||||
|
Revenue |
|
100.0 % |
|
100.0 % |
||||
|
Operating expenses (1) |
886,052 |
79.3 |
699,233 |
81.1 |
||||
|
Gross margin |
230,884 |
20.7 |
162,864 |
18.9 |
||||
|
Corporate general and administrative expenses (1) |
43,128 |
3.9 |
41,334 |
4.8 |
||||
|
Legal settlement, net |
— |
— |
30,468 |
3.5 |
||||
|
Operating income |
187,756 |
16.8 |
91,062 |
10.6 |
||||
|
Other income (expense): |
||||||||
|
Interest expense |
(5,209) |
(0.5) |
(2,852) |
(0.3) |
||||
|
Gain on sale of operations, net |
311 |
— |
6,385 |
0.7 |
||||
|
Other (expense) income, net (1) (2) |
(24,919) |
(2.2) |
12,029 |
1.4 |
||||
|
Total other (expense) income, net |
(29,817) |
(2.7) |
15,562 |
1.8 |
||||
|
Income from continuing operations before income tax expense |
157,939 |
14.1 |
106,624 |
12.4 |
||||
|
Income tax expense |
41,074 |
26,100 |
||||||
|
Income from continuing operations |
116,865 |
10.5 |
80,524 |
9.3 |
||||
|
Loss from operations of discontinued businesses, net of tax |
(13) |
(17) |
||||||
|
Net income |
$ 116,852 |
10.5 % |
$ 80,507 |
9.3 % |
||||
|
Diluted income per share: |
||||||||
|
Continuing operations |
$ 2.22 |
$ 1.50 |
||||||
|
Discontinued operations |
— |
— |
||||||
|
Net income |
$ 2.22 |
$ 1.50 |
||||||
|
Diluted weighted average common shares outstanding |
52,720 |
53,796 |
||||||
|
Other data from continuing operations: |
||||||||
|
Adjusted EBITDA (3) |
$ 194,494 |
|
||||||
|
Adjusted EPS (3) |
$ 2.31 |
$ 1.84 |
||||||
|
(1) |
CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" and "Corporate general and administrative expenses," and are directly offset by deferred compensation gains or losses in "Other (expense) income, net." The deferred compensation plan has no impact on "Income from continuing operations before income tax expense." |
|
Income and expenses related to the deferred compensation plan for the nine months ended |
|
Nine Months Ended |
||||||||
|
2022 |
% of Revenue |
2021 |
% of Revenue |
|||||
|
Operating (income) expenses |
$ (23,000) |
(2.1) % |
$ 11,165 |
1.3 % |
||||
|
Corporate general and administrative (income) expenses |
(3,319) |
(0.3) % |
1,260 |
0.1 % |
||||
|
Other (expense) income, net |
(26,319) |
(2.4) % |
12,425 |
1.4 % |
||||
|
Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the nine months ended |
|
Nine Months Ended |
|||||||||||||||
|
2022 |
2021 |
||||||||||||||
|
As |
Deferred |
Adjusted |
% of |
As |
Deferred |
Adjusted |
% of |
||||||||
|
Gross margin |
|
$ (23,000) |
|
18.6 % |
|
$ 11,165 |
|
20.2 % |
|||||||
|
Operating income |
187,756 |
(26,319) |
161,437 |
14.5 % |
91,062 |
12,425 |
103,487 |
12.0 % |
|||||||
|
Other (expense) income, net |
(24,919) |
26,319 |
1,400 |
0.1 % |
12,029 |
(12,425) |
(396) |
— % |
|||||||
|
Income from continuing operations |
157,939 |
— |
157,939 |
14.1 % |
106,624 |
— |
106,624 |
12.4 % |
|||||||
|
(2) |
Included in "Other (expense) income, net" for the nine months ended |
|
(3) |
Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the most directly comparable GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors. |
|
|
||||||||
|
FINANCIAL HIGHLIGHTS (UNAUDITED) |
||||||||
|
(In thousands) |
||||||||
|
SELECT SEGMENT DATA |
||||||||
|
Three Months Ended |
Nine Months Ended |
|||||||
|
2022 |
2021 |
2022 |
2021 |
|||||
|
Revenue |
||||||||
|
Financial Services |
$ 259,998 |
$ 187,232 |
$ 808,052 |
$ 577,970 |
||||
|
Benefits and Insurance Services |
92,067 |
85,797 |
276,261 |
255,656 |
||||
|
National Practices |
11,197 |
9,690 |
32,623 |
28,471 |
||||
|
Total |
$ 363,262 |
$ 282,719 |
$ 1,116,936 |
$ 862,097 |
||||
|
Gross Margin |
||||||||
|
Financial Services |
$ 39,661 |
$ 31,054 |
$ 168,272 |
$ 129,126 |
||||
|
Benefits and Insurance Services |
18,746 |
16,758 |
55,263 |
51,908 |
||||
|
National Practices |
1,454 |
1,176 |
3,405 |
2,929 |
||||
|
Operating expenses - unallocated (1): |
||||||||
|
Other expense |
(6,611) |
(4,809) |
(19,056) |
(9,934) |
||||
|
Deferred compensation |
3,995 |
212 |
23,000 |
(11,165) |
||||
|
Total |
$ 57,245 |
$ 44,391 |
$ 230,884 |
$ 162,864 |
||||
|
(1) |
Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, consolidation and integration charges, and certain advertising expenses. "Operating expenses - unallocated" also includes gains or losses attributable to the assets held in a rabbi trust associated with the Company's deferred compensation plan. These gains or losses do not impact "Income from continuing operations before income tax expense" as they are directly offset by the same adjustment to "Other (expense) income, net" in the Consolidated Statements of Comprehensive Income. Net gains/losses recognized from adjustments to the fair value of the assets held in the rabbi trust are recorded as compensation expense (income) in "Operating expenses" and "Corporate, general and administrative expenses," and offset in "Other (expense) income, net." |
|
|
||||
|
SELECT CASH FLOW DATA (UNAUDITED) |
||||
|
(In thousands) |
||||
|
Nine Months Ended |
||||
|
2022 |
2021 |
|||
|
Net income |
$ 116,852 |
$ 80,507 |
||
|
Adjustments to reconcile net income to net cash provided by operating activities: |
||||
|
Depreciation and amortization expense |
24,707 |
19,921 |
||
|
Gain on sale of operations, net |
(311) |
(6,385) |
||
|
Bad debt expense, net of recoveries |
1,295 |
562 |
||
|
Adjustments to contingent earnout liability, net |
1,917 |
1,599 |
||
|
Stock-based compensation expense |
11,987 |
8,359 |
||
|
Other noncash adjustments |
3,607 |
6,768 |
||
|
Net income, after adjustments to reconcile net income to net cash provided by operating activities |
160,054 |
111,331 |
||
|
Changes in assets and liabilities, net of acquisitions and divestitures |
(99,982) |
(30,367) |
||
|
Operating cash flows provided by continuing operations |
60,072 |
80,964 |
||
|
Operating cash used in discontinued operations |
(13) |
(18) |
||
|
Net cash provided by operating activities |
60,059 |
80,946 |
||
|
Net cash used in investing activities |
(95,550) |
(70,728) |
||
|
Net cash provided by financing activities |
6,025 |
1,678 |
||
|
Net (decrease) increase in cash, cash equivalents and restricted cash |
(29,466) |
11,896 |
||
|
Cash, cash equivalents and restricted cash at beginning of year |
$ 150,474 |
$ 170,335 |
||
|
Cash, cash equivalents and restricted cash at end of period |
$ 121,008 |
$ 182,231 |
||
|
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheet: |
||||
|
Cash and cash equivalents |
$ 2,040 |
$ 2,749 |
||
|
Restricted cash |
39,555 |
37,320 |
||
|
Cash equivalents included in funds held for clients |
79,413 |
142,162 |
||
|
Total cash, cash equivalents and restricted cash |
$ 121,008 |
$ 182,231 |
||
|
|
||||
|
SELECT FINANCIAL DATA AND RATIOS (UNAUDITED) |
||||
|
(In thousands) |
||||
|
|
|
|||
|
Cash and cash equivalents |
2,040 |
1,997 |
||
|
Restricted cash |
39,555 |
30,383 |
||
|
Accounts receivable, net |
398,970 |
242,168 |
||
|
Current assets before funds held for clients |
457,630 |
293,765 |
||
|
Funds held for clients |
125,451 |
157,909 |
||
|
|
957,186 |
840,783 |
||
|
Total assets |
1,899,618 |
1,627,934 |
||
|
Current liabilities before client fund obligations |
330,513 |
265,174 |
||
|
Client fund obligations |
128,091 |
158,115 |
||
|
Total long-term debt, net |
268,936 |
154,851 |
||
|
Total liabilities |
1,125,493 |
923,386 |
||
|
|
(769,981) |
(694,716) |
||
|
Total stockholders' equity |
774,125 |
704,548 |
||
|
Debt to equity |
34.7 % |
22.0 % |
||
|
Days sales outstanding (DSO) - continuing operations (1) |
93 |
71 |
||
|
Shares outstanding |
51,181 |
52,038 |
||
|
Basic weighted average common shares outstanding |
51,827 |
52,637 |
||
|
Diluted weighted average common shares outstanding |
52,720 |
53,723 |
||
|
(1) |
DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing twelve month daily revenue. The Company has included DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of the Company's ability to collect on receivables in a timely manner. DSO should not be regarded as an alternative or replacement to any measurement of performance under GAAP. DSO on |
|
|
||||||||
|
GAAP RECONCILIATION |
||||||||
|
Income from Continuing Operations to Adjusted EBITDA (1) |
||||||||
|
(In thousands) |
||||||||
|
Three Months Ended |
Nine Months Ended |
|||||||
|
2022 |
2021 |
2022 |
2021 |
|||||
|
Income from continuing operations |
$ 27,474 |
$ 21,695 |
$ 116,865 |
$ 80,524 |
||||
|
Interest expense |
2,305 |
1,016 |
5,209 |
2,852 |
||||
|
Income tax expense |
9,131 |
7,512 |
41,074 |
26,100 |
||||
|
Gain on sale of operations, net |
(176) |
— |
(311) |
(6,385) |
||||
|
Gain on sale of assets, net |
(2,391) |
— |
(2,391) |
— |
||||
|
Legal settlement, net |
— |
— |
— |
30,468 |
||||
|
Transaction costs related to |
— |
— |
1,329 |
— |
||||
|
Integration & retention costs related to |
1,280 |
— |
8,012 |
— |
||||
|
Depreciation |
2,771 |
2,808 |
8,378 |
8,010 |
||||
|
Amortization |
5,471 |
4,237 |
16,329 |
11,911 |
||||
|
Adjusted EBITDA |
$ 45,865 |
$ 37,268 |
$ 194,494 |
$ 153,480 |
||||
|
(1) |
CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted EBITDA to the most directly comparable GAAP financial measure, "Income from continuing operations." Adjusted EBITDA is not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted EBITDA is commonly used by the Company, its shareholders and debt holders as a performance measurement to evaluate, assess and benchmark the Company's operational results. |
|
(2) |
These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. |
|
|
|||||||
|
GAAP RECONCILIATION |
|||||||
|
Income and Diluted Earnings Per Share ("EPS") from Continuing Operations to Adjusted Income and EPS(1) |
|||||||
|
(In thousands, except per share data) |
|||||||
|
Three Months Ended |
Three Months Ended |
||||||
|
Amounts |
EPS |
Amounts |
EPS |
||||
|
Income from continuing operations |
$ 27,474 |
$ 0.53 |
$ 21,695 |
$ 0.41 |
|||
|
Adjustments: |
|||||||
|
Gain on sale of operations, net |
(176) |
— |
— |
— |
|||
|
Gain on sale of assets, net |
(2,391) |
(0.05) |
— |
— |
|||
|
Integration & retention costs related to |
1,280 |
0.02 |
— |
— |
|||
|
Income tax effect related to adjustments |
321 |
0.01 |
— |
— |
|||
|
Adjusted income from continuing operations |
$ 26,508 |
$ 0.51 |
$ 21,695 |
$ 0.41 |
|||
|
(1) |
CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted Income and Adjusted EPS to the most directly comparable GAAP financial measures, "Income from continuing operations" and "Diluted earnings per share from continuing operations." Adjusted Income and Adjusted EPS are not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted Income and Adjusted EPS, which excludes significant non-operating related gains and losses, are used by the Company for its shareholders and debt holders as a performance measure to evaluate, assess and benchmark the Company's operational results. |
|
(2) |
These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. |
|
Nine Months Ended |
Nine Months Ended |
||||||
|
Amounts |
EPS |
Amounts |
EPS |
||||
|
Income from continuing operations |
$ 116,865 |
$ 2.22 |
$ 80,524 |
$ 1.50 |
|||
|
Adjustments: |
|||||||
|
Gain on sale of operations, net |
(311) |
(0.01) |
(6,385) |
(0.12) |
|||
|
Gain on sale of assets, net |
(2,391) |
(0.05) |
— |
— |
|||
|
Legal settlement, net |
— |
— |
30,468 |
0.57 |
|||
|
Transaction costs related to |
1,329 |
0.03 |
— |
— |
|||
|
Integration & retention costs related to |
8,012 |
0.15 |
— |
— |
|||
|
Income tax effect related to adjustments |
(1,727) |
(0.03) |
(5,896) |
(0.11) |
|||
|
Adjusted income from continuing operations |
$ 121,777 |
$ 2.31 |
$ 98,711 |
$ 1.84 |
|||
|
(1) |
CBIZ reports its financial results in accordance with GAAP. This table reconciles Adjusted Income and Adjusted EPS to the most directly comparable GAAP financial measures, "Income from continuing operations" and "Diluted earnings per share from continuing operations." Adjusted Income and Adjusted EPS are not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance under GAAP. Adjusted Income and Adjusted EPS, which excludes significant non-operating related gains and losses, are used by the Company for its shareholders and debt holders as a performance measure to evaluate, assess and benchmark the Company's operational results. |
|
(2) |
These costs include, but are not limited to, certain consulting, technology, personnel, as well as other first year operating and general administrative costs that are non-recurring in nature. |
|
|
|||
|
GAAP RECONCILIATION |
|||
|
Full Year 2022 EPS from Continuing Operations Guidance to Full Year 2022 Adjusted Diluted EPS |
|||
|
Full Year 2022 Guidance |
|||
|
Low |
High |
||
|
Diluted EPS - GAAP Guidance |
$ 1.96 |
$ 1.99 |
|
|
Transaction and integration costs related to |
0.16 |
0.16 |
|
|
Gain on sale of asset, net |
(0.03) |
(0.03) |
|
|
Adjusted Diluted EPS Guidance |
$ 2.09 |
$ 2.12 |
|
|
GAAP Diluted EPS for 2021 |
$ 1.32 |
$ 1.32 |
|
|
Adjusted Diluted EPS for 2021 (2) |
$ 1.66 |
$ 1.66 |
|
|
|
48 % |
51 % |
|
|
Adjusted Diluted EPS Range |
26 % |
28 % |
|
|
(1) |
Includes estimated transaction and integration costs related to the |
|
(2) |
A reconciliation between income from continuing operations and adjusted income from continuing operations and a reconciliation between GAAP Diluted EPS and Adjusted Diluted EPS for fiscal year ended |
|
Year Ended |
|||
|
In thousands |
EPS |
||
|
Income from continuing operations |
$ 70,911 |
$ 1.32 |
|
|
Adjustments: |
|||
|
Gain on sale of operations, net |
(6,311) |
(0.12) |
|
|
Legal settlement, net |
30,468 |
0.57 |
|
|
Income tax effect related to adjustments |
(5,746) |
(0.11) |
|
|
Adjusted income from continuing operations |
$ 89,322 |
$ 1.66 |
|
View original content:https://www.prnewswire.com/news-releases/cbiz-reports-third-quarter-and-nine-month-2022-results-and-increases-full-year-2022-guidance-301660510.html
SOURCE
Ware Grove, Chief Financial Officer -or- Lori Novickis, Director, Corporate Relations, CBIZ, Inc., Cleveland, Ohio, (216) 447-9000
